News

Health Canada has issued a risk communication to health care professionals, notifying them of a review of Tavneos (avacopan), a medication used for the treatment of a rare autoimmune disease that can affect the kidneys and other organs.

Itching affects thousands of people living with chronic kidney disease (CKD) yet remains one of the most overlooked and least discussed symptoms. It is more than a minor irritation. For many, itch is unbearable as it disrupts sleep, affects mental health, and lowers quality of life.